Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System
NCT05882136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2024-04-02
Summary
This study aims to assess the changes in the cardiovascular system in patients with acute intermittent porphyria (AIP).
Conditions
- Porphyrias, Hepatic
Sponsors & Collaborators
-
Institute of Hematology and Transfusion Medicine, Warsaw
collaborator OTHER -
National Institute of Cardiology, Warsaw, Poland
lead OTHER
Principal Investigators
-
Krzysztof Jaworski, MD · National Institute of Cardiology, Warsaw, Poland
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-05
- Primary Completion
- 2024-02-28
- Completion
- 2024-02-28
Countries
- Poland
Study Locations
More Related Trials
-
Study of Nutritional Factors in Porphyria
NCT00004788 ·Status: COMPLETED
-
Heart Disease in Sickle Cell Anemia
NCT00113152 ·Status: COMPLETED
-
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
NCT01688895 ·Status: COMPLETED
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED
-
Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
NCT05583721 ·Status: RECRUITING ·Phase: PHASE2
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Acute Porphyria Biomarkers for Disease Activity
NCT02935400 ·Status: ACTIVE_NOT_RECRUITING
-
Cardiovascular Complications of Sickle Cell Disease
NCT01044901 ·Status: COMPLETED
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose
NCT03114137 ·Status: UNKNOWN
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis
NCT01683968 ·Status: UNKNOWN
-
Studies in Porphyria I: Characterization of Enzyme Defects
NCT00004331 ·Status: UNKNOWN
-
Study of the Pathogenesis of Porphyria Cutanea Tarda
NCT00005103 ·Status: COMPLETED
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation in Beta-Thalassemia
NCT05508932 ·Status: RECRUITING
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED
-
Clinical and Laboratory Characteristics of Polycythemia Vera
NCT06134102 ·Status: COMPLETED
-
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004396 ·Status: COMPLETED ·Phase: PHASE2
-
Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
NCT02394431 ·Status: COMPLETED
-
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
NCT07023666 ·Status: RECRUITING ·Phase: PHASE2
-
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
NCT03458897 ·Status: COMPLETED ·Phase: NA
-
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease
NCT00528801 ·Status: COMPLETED
-
Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
NCT04128943 ·Status: COMPLETED